Conflict of interest in seminal hepatitis C virus and cholesterol management guidelines

JAMA Internal Medicine

Volumn 177, Issue 3, 2017, Pages 352-357

  Jefferson, Akilah A ^a   Pearson, Steven D ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFLICT OF INTEREST; CONSULTATION; HEPATITIS C; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL RECORD REVIEW; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PROTOCOL COMPLIANCE; RETROSPECTIVE STUDY; REVIEW; DISEASE MANAGEMENT; ETHICS; FINANCIAL MANAGEMENT; HYPERCHOLESTEROLEMIA; MANAGEMENT; ORGANIZATION; ORGANIZATION AND MANAGEMENT; STANDARDS; UNITED STATES;

CONFLICT OF INTEREST; DISCLOSURE; DISEASE MANAGEMENT; FINANCIAL SUPPORT; HEPATITIS C; HUMANS; HYPERCHOLESTEROLEMIA; NATIONAL ACADEMIES OF SCIENCE, ENGINEERING, AND MEDICINE (U.S.) HEALTH AND MEDICINE DIVISION; POLICY MAKING; PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 85015289897     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2016.8439     Document Type: Review

References (25)

1. American Medical Association. Ethical considerations in the development of clinical practice guidelines H-410.953. https://searchpf.ama-assn.org/SearchML/searchDetails.action?uri=%2FAMADoc%2FHOD.xml-0-3636.xml. Published 2014. Accessed April 11, 2016.
2. Woolf SH, Grol R, Hutchinson A, EcclesM, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318(7182):527-530.
3. Jacobs AK, Anderson JL, Halperin JL, et al; ACC/AHA Task Force Members. The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130 (14):1208-1217.
4. Graham R, Mancher M, MillerWolman D, Greenfield S, Steinberg E, eds; Committee on Standards for Developing Trustworthy Clinical Practice Guidelines; Institute of Medicine. Clinical Practice GuidelinesWe Can Trust.Washington, DC: National Academy of Sciences; 2011.
5. Lenzer J, Hoffman JR, Furberg CD, Ioannidis JP; Guideline Panel ReviewWorking Group. Ensuring the integrity of clinical practice guidelines: a tool for protecting patients. BMJ. 2013;347:f5535.
6. Stone NJ, Robinson JG, Lichtenstein AH, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2014;129(25)(suppl 2):S46-S48]. Circulation. 2014;129(25)(suppl 2):S1-S45.
7. AASLD/IDSA HCV Guidance Panel. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology. 2015;62(3):932-954.
8. Kodjak A. Hepatitis drug among the most costly for Medicaid. National Public Radio. December 15, 2015.
9. Park A. Should I take a statin? what you need to know about the new cholesterol guidelines. Time. 2013(November):20.
10. DeBoy AM. Assuring Medicaid Beneficiaries Access to Hepatitis C (HCV) Drugs. Baltimore, MD: Center for Medicaid & CHIP Services; November 5, 2015. Medicaid Drug Rebate Program Notice Release 172.
11. Yee HF Jr. Treatment of hepatitis C virus infection in real life. JAMA Intern Med. 2016;176(1): 73-74.
12. Martin SS, Blumenthal RS. Concepts and controversies: the 2013 American College of Cardiology/American Heart Association risk assessment and cholesterol treatment guidelines. Ann Intern Med. 2014;160(5):356-358.
13. Lo B, Field MJ, eds; Institute of Medicine Committee on Conflict of Interest in Medical Research, Education, and Practice. Conflict of Interest in Medical Research, Education, and Practice. Washington, DC: National Academy of Sciences; 2009.
14. Schünemann HJ, Al-Ansary LA, Forland F, et al; Board of Trustees of the Guidelines International Network. Guidelines International Network: principles for disclosure of interests and management of conflicts in guidelines. Ann Intern Med. 2015;163(7):548-553.
15. American College of Cardiology Foundation and American Heart Association, Inc. Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines. http://professional.heart.org/idc/groups/ahamah-public/@wcm/@sop/documents/downloadable/ucm-319826.pdf. Published June 2010. Accessed August 1, 2016.
16. Lenzer J. Majority of panelists on controversial new cholesterol guideline have current or recent ties to drug manufacturers. BMJ. 2013;347:f6989.
17. Park A. Conflicts of interest: cholesterol panel head defends members' ties to industry. Time. 2013 (November):22.
18. Stone NJ. Nonpharmacologic management of mixed dyslipidemia associated with diabetes mellitus and the metabolic syndrome: a review of the evidence. Am J Cardiol. 2008;102(12):14L-18L.
19. Downs JR, O'Malley PG. Management of dyslipidemia for cardiovascular disease risk reduction: synopsis of the 2014 U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guideline. Ann Intern Med. 2015;163 (4):291-297.
20. Department of Veterans Affairs. Chronic hepatitis C virus (HCV) infection: treatment considerations from the Department of Veterans Affairs National Hepatitis C Resource Center Program and the Office of Public Health. http://www.hepatitis.va.gov/pdf/2014hcv.pdf. Published March 27, 2014. Accessed September 1, 2016.
21. Drazen JM, Van DerWeyden MB, Sahni P, et al. Uniform format for disclosure of competing interests in ICMJE journals. Lancet. 2009;374 (9699):1395-1396.
22. Guyatt G, Akl EA, Hirsh J, et al. The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med. 2010;152(11): 738-741.
23. Brawley O, Byers T, Chen A, et al. New American Cancer Society process for creating trustworthy cancer screening guidelines. JAMA. 2011;306(22):2495-2499.
24. American College of Cardiology. Relationships with industry policy. http://www.acc.org/guidelines/about-guidelines-and-clinical-documents/relationships-with-industry-policy. Published May 17, 2010. Accessed August 1, 2016.
25. American Association for the Study of Liver Diseases. Code for the assessment and management of conflict of interest. http://www.aasld.org/governance-codes-site-data-policy/code-assessment-and-management-conflict-interest. Published October 2010. Accessed August 1, 2016.